Nutrien Announces TSX Approval for Its Renewed Share Repurchase Program
Nutrien (TSX and NYSE: NTR) has received TSX approval for a new normal course issuer bid (NCIB) to repurchase up to 5% of its outstanding common shares, equivalent to 24,462,941 shares. The program will run from March 3, 2025, to March 2, 2026.
The company will conduct purchases through the TSX, NYSE, and alternative trading systems in Canada and the U.S. Daily purchases on TSX will be to 449,538 shares, representing 25% of the average daily trading volume. Under the previous NCIB expiring February 28, 2025, Nutrien repurchased 5,832,440 shares at a weighted average price of US$48.44, totaling US$282.5 million.
Nutrien views the share repurchase as an attractive investment opportunity aligned with its capital return objectives. The company has implemented an automatic purchase plan allowing share acquisitions during self-imposed blackout periods.
Nutrien (TSX e NYSE: NTR) ha ricevuto l'approvazione dalla TSX per una nuova offerta di acquisto normale (NCIB) per riacquistare fino al 5% delle sue azioni ordinarie in circolazione, equivalente a 24.462.941 azioni. Il programma sarà attivo dal 3 marzo 2025 al 2 marzo 2026.
L'azienda effettuerà acquisti tramite la TSX, NYSE e sistemi di trading alternativi in Canada e negli Stati Uniti. Gli acquisti giornalieri sulla TSX saranno limitati a 449.538 azioni, corrispondenti al 25% del volume medio giornaliero di scambi. Nell'ambito del precedente NCIB che scade il 28 febbraio 2025, Nutrien ha riacquistato 5.832.440 azioni a un prezzo medio ponderato di 48,44 USD, per un totale di 282,5 milioni di USD.
Nutrien considera il riacquisto di azioni un'opportunità di investimento interessante, in linea con i suoi obiettivi di ritorno di capitale. L'azienda ha implementato un piano di acquisto automatico che consente acquisizioni di azioni durante i periodi di blackout autoimposti.
Nutrien (TSX y NYSE: NTR) ha recibido la aprobación de la TSX para una nueva oferta de compra normal (NCIB) para recomprar hasta el 5% de sus acciones ordinarias en circulación, equivalente a 24,462,941 acciones. El programa se llevará a cabo desde el 3 de marzo de 2025 hasta el 2 de marzo de 2026.
La empresa realizará compras a través de la TSX, NYSE y sistemas de negociación alternativos en Canadá y EE. UU. Las compras diarias en la TSX estarán limitadas a 449,538 acciones, lo que representa el 25% del volumen medio diario de negociación. En el marco de la NCIB anterior que expira el 28 de febrero de 2025, Nutrien recompró 5,832,440 acciones a un precio medio ponderado de 48.44 USD, totalizando 282.5 millones de USD.
Nutrien considera la recompra de acciones como una oportunidad de inversión atractiva alineada con sus objetivos de retorno de capital. La empresa ha implementado un plan de compra automática que permite adquisiciones de acciones durante los períodos de bloqueo autoimpuestos.
뉴트리엔(NTR, TSX 및 NYSE)은 자사 보통주 5%에 해당하는 24,462,941주를 재매입하기 위한 새로운 정상 매입 제안(NCIB)에 대해 TSX의 승인을 받았습니다. 이 프로그램은 2025년 3월 3일부터 2026년 3월 2일까지 진행됩니다.
회사는 캐나다와 미국에서 TSX, NYSE 및 대체 거래 시스템을 통해 매입을 진행할 것입니다. TSX에서의 일일 매입은 449,538주로 제한되며, 이는 평균 일일 거래량의 25%에 해당합니다. 2025년 2월 28일에 만료되는 이전 NCIB 하에서 뉴트리엔은 평균 가중 가격 48.44 USD로 5,832,440주를 재매입하여 총 2억 8,250만 USD에 달했습니다.
뉴트리엔은 주식 재매입을 자본 반환 목표에 부합하는 매력적인 투자 기회로 보고 있습니다. 회사는 자율적으로 설정한 블랙아웃 기간 동안 주식을 매입할 수 있도록 자동 매입 계획을 시행했습니다.
Nutrien (TSX et NYSE : NTR) a reçu l'approbation de la TSX pour une nouvelle offre de rachat normale (NCIB) visant à racheter jusqu'à 5 % de ses actions ordinaires en circulation, soit 24 462 941 actions. Le programme se déroulera du 3 mars 2025 au 2 mars 2026.
L'entreprise effectuera des achats via la TSX, la NYSE et des systèmes de négociation alternatifs au Canada et aux États-Unis. Les achats quotidiens sur la TSX seront limités à 449 538 actions, représentant 25 % du volume moyen quotidien des échanges. Dans le cadre de la précédente NCIB qui expire le 28 février 2025, Nutrien a racheté 5 832 440 actions à un prix moyen pondéré de 48,44 USD, pour un total de 282,5 millions USD.
Nutrien considère le rachat d'actions comme une opportunité d'investissement attrayante, en accord avec ses objectifs de retour de capital. L'entreprise a mis en place un plan d'achat automatique permettant l'acquisition d'actions pendant les périodes de blackout auto-imposées.
Nutrien (TSX und NYSE: NTR) hat die Genehmigung der TSX für ein neues normales Rückkaufangebot (NCIB) erhalten, um bis zu 5% seiner ausstehenden Stammaktien zurückzukaufen, was 24.462.941 Aktien entspricht. Das Programm läuft vom 3. März 2025 bis zum 2. März 2026.
Das Unternehmen wird Käufe über die TSX, NYSE und alternative Handelssysteme in Kanada und den USA durchführen. Tägliche Käufe an der TSX werden auf 449.538 Aktien begrenzt, was 25% des durchschnittlichen täglichen Handelsvolumens entspricht. Im Rahmen des vorherigen NCIB, das am 28. Februar 2025 ausläuft, hat Nutrien 5.832.440 Aktien zu einem gewichteten Durchschnittspreis von 48,44 USD zurückgekauft, was insgesamt 282,5 Millionen USD entspricht.
Nutrien betrachtet den Aktienrückkauf als eine attraktive Investitionsmöglichkeit, die mit seinen Zielen zur Kapitalrückführung in Einklang steht. Das Unternehmen hat einen automatischen Kaufplan implementiert, der den Erwerb von Aktien während selbstauferlegter Sperrfristen ermöglicht.
- New 5% share buyback program approved
- Automatic purchase plan implemented for consistent execution
- Previous buyback executed at favorable price of US$48.44/share
- Demonstrates commitment to returning capital to shareholders
- Previous buyback utilized only 23.6% of authorized amount
- Significant cash outlay required for program execution
Insights
Nutrien's renewal of its share repurchase program authorizing buybacks of up to 24.46 million shares (5% of outstanding) represents a significant capital allocation decision with several important implications for investors.
The company's execution of its previous authorization provides critical context - Nutrien repurchased only 5.83 million shares (23.6% of authorized) at
With Nutrien's current share price around
The buyback represents approximately
Importantly, this buyback authorization complements rather than replaces Nutrien's dividend program, reflecting a balanced approach to shareholder returns. For agricultural input companies facing cyclical demand, maintaining flexibility in capital return mechanisms is strategically advantageous compared to committing solely to dividend increases that might become unsustainable during industry downturns.
Under the NCIB, purchases of common shares may be made through the facilities of the TSX, the New York Stock Exchange and/or alternative trading systems in
The NCIB will be effected in accordance with the TSX normal course issuer bid rules and/or Rule 10b-18 under the
Nutrien's prior NCIB for the purchase of up to 24,728,159 common shares will expire on February 28, 2025. As of February 18, 2025, Nutrien repurchased an aggregate of 5,832,440 common shares at a weighted-average price of
About Nutrien
Nutrien is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of farmers. We focus on creating long-term value by prioritizing investments that strengthen the advantages of our business across the ag value chain and by maintaining access to the resources and the relationships with stakeholders needed to achieve our goals.
Forward-Looking Statements
Certain statements and other information included in this press release constitute "forward-looking information" or "forward-looking statements" (collectively, "forward-looking statements") under applicable securities laws (such statements are usually accompanied by words such as "anticipate", "expect", "believe", "may", "will", "should", "project", "estimate", "intend" or other similar words). All statements in this press release, other than those relating to historical information or current conditions, are forward-looking statements, including, but not limited to the timing, methods and quantity of any purchases by Nutrien of its common shares under the NCIB.
Forward-looking statements in this press release are based on certain key expectations and assumptions made by Nutrien, including expectations and assumptions concerning: Nutrien's views with respect to its financial condition and prospects, the stability of general economic and market conditions, currency exchange rates and interest rates, the availability of cash for repurchases of common shares under the NCIB, the existence of alternative uses for Nutrien's cash resources and compliance with applicable laws and regulations pertaining to the NCIB. Although Nutrien believes that the expectations and assumptions on which such forward looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because Nutrien can give no assurance that they will prove to be correct.
Forward-looking statements are subject to various risks and uncertainties which could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this press release. The key risks and uncertainties include, but are not limited to: Nutrien's future capital requirements; general economic and market conditions; the overall global economy and the impacts, direct and indirect, of the war between
The forward-looking statements in this document are made as of the date hereof and Nutrien disclaims any intention or obligation to update or revise any forward-looking statements in this press release as a result of new information or future events, except as may be required under applicable laws.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250226636858/en/
FOR FURTHER INFORMATION:
Jeff Holzman
Vice President, Investor Relations
(306) 933-8545
Contact us at: www.nutrien.com
Source: Nutrien Ltd.
FAQ
How many shares can Nutrien (NTR) repurchase under the new buyback program?
What is the duration of Nutrien's (NTR) new share repurchase program?
How many shares did Nutrien (NTR) repurchase under its previous buyback program?